Exact Mass: 379.0689814000001

Exact Mass Matches: 379.0689814000001

Found 204 metabolites which its exact mass value is equals to given mass value 379.0689814000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

S-Lactoylglutathione

(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-{[(2R)-2-hydroxypropanoyl]sulfanyl}ethyl]carbamoyl}butanoic acid

C13H21N3O8S (379.10493060000005)


S-Lactoylglutathione is a substrate of lactoylglutathione lyase [EC 4.4.1.5] in pyruvate metabolism (KEGG). Another enzyme, glyoxalase I, synthesizes this compound by converting methylglyoxal and reduced glutathione to S-lactoylglutathione. S-D-lactoylglutathione can be hydrolysed by thiolesterases to reduced glutathione and D-lactate but also converted to N-D-lactoylcysteinylglycine and N-D-lactoylcysteine by gamma-glutamyl transferase and dipeptidase (PMID: 8632674). S-lactoylglutathione has also been shown to modulate microtubule assembly (PMID: 690442). [HMDB]. S-Lactoylglutathione is found in many foods, some of which are blackcurrant, oat, pomegranate, and brussel sprouts. S-Lactoylglutathione is a substrate of lactoylglutathione lyase [EC 4.4.1.5] in pyruvate metabolism (KEGG). Another enzyme, glyoxalase I, synthesizes this compound by converting methylglyoxal and reduced glutathione to S-lactoylglutathione. S-D-lactoylglutathione can be hydrolysed by thiolesterases to reduced glutathione and D-lactate but also converted to N-D-lactoylcysteinylglycine and N-D-lactoylcysteine by gamma-glutamyl transferase and dipeptidase (PMID: 8632674). S-lactoylglutathione has also been shown to modulate microtubule assembly (PMID: 690442). Acquisition and generation of the data is financially supported in part by CREST/JST. D000970 - Antineoplastic Agents KEIO_ID L016; [MS3] KO009026 KEIO_ID L016; [MS2] KO009024 KEIO_ID L016

   

SCHEMBL842167

N-acetyl-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-D-galactosamine

C14H21NO11 (379.1114556)


   

12-Hydroxychelirubine

12-Hydroxydihydrochelirubine

C21H17NO6 (379.1055822)


   
   

2-Bromo-5-hydroxy-N-(4-hydroxyphenethyl)-4-methoxy-N-methylbenzamide

2-Bromo-5-hydroxy-N-[2-(4-hydroxyphenyl)ethyl]-4-methoxy-N-methylbenzamide

C17H18BrNO4 (379.04191280000003)


   

Azo-mustard

2-Carboxy-4-[bis(2-chloroethyl)amino]-2-methylazobenzene

C18H19Cl2N3O2 (379.0854254)


   

6-Thioguanosine monophosphate

{[(2R,3S,4R,5R)-5-(2-amino-6-sulfanylidene-6,9-dihydro-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H14N5O7PS (379.03515440000007)


6-Thioguanosine monophosphate is a metabolite of tioguanine. Tioguanine, formerly thioguanine, is a drug that is used in the treatment of cancer. It belongs to the family of drugs called antimetabolites. It is a guanine analog. (Wikipedia) Norcodeine

   

Gonyautoxin V

N-SulphO({10,10-dihydroxy-2,6-diimino-decahydropyrrolo[1,2-c]purin-4-yl}methoxy)carboximidic acid

C10H17N7O7S (379.0910132)


Gonyautoxin V is found in mollusks. Gonyautoxin V is produced by Gonyaulax and Protogonyaulax species. Production by Gonyaulax and Protogonyaulax subspecies Gonyautoxin V is found in mollusks. D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms

   

Hyaluronan biosynthesis, precursor 1

(2R,3R,4S)-2-{[(2R,3R,4R,5S,6R)-2,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-4-yl]oxy}-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO11 (379.1114556)


This compound belongs to the family of N-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moeity in which the oxygen atom is replaced by an n-acyl group.

   

8-Oxoguanosine 5-phosphate

8-Oxoguanosine 5-phosphate

C10H14N5O9P (379.0529124)


   

(R)-S-lactoylglutathionate(1-)

2-Amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-hydroxypropanoyl)sulphanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C13H21N3O8S (379.10493060000005)


(R)-S-lactoylglutathionate(1-) is also known as (R)-S-Lactoylglutathionic acid anion. (R)-S-lactoylglutathionate(1-) is considered to be slightly soluble (in water) and acidic

   

Griseolic acid

5-(6-amino-9H-purin-9-yl)-2-[carboxy(hydroxy)methyl]-6-hydroxy-2H,5H,6H,6aH-furo[3,2-b]furan-2-carboxylic acid

C14H13N5O8 (379.0764098)


   

Methyl 2-(2-acetoxy-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-2-(2-chlorophenyl)acetate

Methyl 2-[2-(acetyloxy)-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl]-2-(2-chlorophenyl)acetic acid

C18H18ClNO4S (379.0645018000001)


   

2-({6-Amino-3,5-dicyano-4-[4-(cyclopropylmethoxy)phenyl]pyridin-2-yl}sulfanyl)acetamide

2-({6-amino-3,5-dicyano-4-[4-(cyclopropylmethoxy)phenyl]pyridin-2-yl}sulphanyl)acetamide

C19H17N5O2S (379.1102902)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists BAY 60-6583 is a potent and high-affinity agonist of adenosine A2B receptor (EC50?= 3 nM) over A1, A2A, and A3 receptors. BAY 60-6583 binds to mouse, rabbit, and dog A2BAR with Ki values of 750 nM, 340 nM and 330 nM, respectively. BAY 60-6583 has a cardioprotective effect in a myocardial ischemia model[1][5].

   

[2,3-e]-1,2-Thiazine-6-sulfonamide 1,1-Dioxide 1

2-methyl-3-[(morpholin-4-yl)methyl]-1,1-dioxo-2H-1lambda6-thieno[2,3-e][1,2]thiazine-6-sulfonamide

C12H17N3O5S3 (379.03303120000004)


   

Cyclopenthiazide

6-chloro-3-(cyclopentylmethyl)-1,1-dioxo-3,4-dihydro-2H-1λ⁶,2,4-benzothiadiazine-7-sulfonamide

C13H18ClN3O4S2 (379.0427218)


C - Cardiovascular system > C03 - Diuretics > C03A - Low-ceiling diuretics, thiazides > C03AA - Thiazides, plain D045283 - Natriuretic Agents > D004232 - Diuretics > D049993 - Sodium Chloride Symporter Inhibitors C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators

   

Dimethane sulfonate

2-[(4-Formyl-3-methylphenyl)[2-(methanesulphonyloxy)ethyl]amino]ethyl methanesulphonic acid

C14H21NO7S2 (379.0759396)


   

N-(p-Toluenesulfonyl)-L-phenylalanyl Chloromethyl Ketone

N-(5-Chloro-3,4-dioxo-1-phenylpentan-2-yl)-4-methylbenzene-1-sulphonamide

C18H18ClNO4S (379.0645018000001)


   

2-Amino-5-[[1-[carboxymethyl(2-hydroxypropanoyl)amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid

2-Amino-4-({1-[N-(carboxymethyl)-2-hydroxypropanamido]-1-oxo-3-sulphanylpropan-2-yl}-C-hydroxycarbonimidoyl)butanoic acid

C13H21N3O8S (379.10493060000005)


   

[(2R,5R)-5-(2-Amino-6-sulfanylidene-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

[(2R,5R)-5-(2-Amino-6-sulphanylidene-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphoric acid

C10H14N5O7PS (379.03515440000007)


   

Cyclohexanecarboxamide, N-(2-((ethylsulfonyl)amino)-5-(trifluoromethyl)-3-pyridinyl)-

N-((2-Ethylsulfonylamino)-5-trifluoromethyl-3-pyridyl)cyclohexanecarboxamide monohydrate sodium salt

C15H20F3N3O3S (379.11774060000005)


   
   
   
   
   

12-Hydroxydihydrochelirubine

12-Hydroxydihydrochelirubine

C21H17NO6 (379.1055822)


A benzophenanthridine alkaloid comprising dihydrochelirubine carrying a hydroxy substituent at the 12-position.

   
   

3-(2,3-Dihydro-1H-indol-1-yl)-2-{[5-(trifluoromethyl)-2-pyridyl]sulfonyl}acrylonitrile

3-(2,3-Dihydro-1H-indol-1-yl)-2-{[5-(trifluoromethyl)-2-pyridyl]sulfonyl}acrylonitrile

C17H12F3N3O2S (379.0602288)


   

Pyridinium-3,5-biscarboxylic acid mononucleotide; P2CMN; Pyridin-1-ium-3,5-dicarboxylate mononucleotide; Pyridinium-3,5-biscarboxylate mononucleotide

Pyridinium-3,5-biscarboxylic acid mononucleotide; P2CMN; Pyridin-1-ium-3,5-dicarboxylate mononucleotide; Pyridinium-3,5-biscarboxylate mononucleotide

C12H14NO11P (379.0304464)


   

2-(4-Hydroxyphenyl)-2-(5-oxopyrrolidine-2-yl)-4-(3,4-dihydroxyphenyl)-4-cyclopentene-1,3-dione

2-(4-Hydroxyphenyl)-2-(5-oxopyrrolidine-2-yl)-4-(3,4-dihydroxyphenyl)-4-cyclopentene-1,3-dione

C21H17NO6 (379.1055822)


   
   

6-methoxy-13-methyl-13,14-dihydro-[1,3]dioxolo[4,5-i][1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-14-ol|Chelirubin|chelirubine

6-methoxy-13-methyl-13,14-dihydro-[1,3]dioxolo[4,5-i][1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-14-ol|Chelirubin|chelirubine

C21H17NO6 (379.1055822)


   
   

2-deoxy-N-glycoloyl-9-O-lactoyl-2,3-didehydroneuraminic acid

2-deoxy-N-glycoloyl-9-O-lactoyl-2,3-didehydroneuraminic acid

C14H21NO11 (379.1114556)


   

Dihydrochelirubine -5-Hydroxy

Dihydrochelirubine -5-Hydroxy

C21H17NO6 (379.1055822)


   
   
   

Isocoptisine acetate

Pseudocoptisine (acetate)

C21H17NO6 (379.1055822)


   
   

Cys Gly Asn Ser

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C12H21N5O7S (379.11616360000005)


   

Cys Gly Ser Asn

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Cys Asn Gly Ser

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]acetamido}-3-hydroxypropanoic acid

C12H21N5O7S (379.11616360000005)


   

Cys Asn Ser Gly

2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]acetic acid

C12H21N5O7S (379.11616360000005)


   

Cys Ser Gly Asn

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]acetamido}-3-carbamoylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Cys Ser Asn Gly

2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]acetic acid

C12H21N5O7S (379.11616360000005)


   
   

Gly Cys Asn Ser

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C12H21N5O7S (379.11616360000005)


   

Gly Cys Ser Asn

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Gly Asn Cys Ser

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C12H21N5O7S (379.11616360000005)


   

Gly Asn Ser Cys

(2R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Gly Ser Cys Asn

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Gly Ser Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

cyclopenthiazide

cyclopenthiazide

C13H18ClN3O4S2 (379.0427218)


C - Cardiovascular system > C03 - Diuretics > C03A - Low-ceiling diuretics, thiazides > C03AA - Thiazides, plain D045283 - Natriuretic Agents > D004232 - Diuretics > D049993 - Sodium Chloride Symporter Inhibitors C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators

   

Asn Cys Gly Ser

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]acetamido}-3-hydroxypropanoic acid

C12H21N5O7S (379.11616360000005)


   

Asn Cys Ser Gly

2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-hydroxypropanamido]acetic acid

C12H21N5O7S (379.11616360000005)


   

Asn Gly Cys Ser

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C12H21N5O7S (379.11616360000005)


   

Asn Gly Ser Cys

(2R)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-hydroxypropanamido]-3-sulfanylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Asn Ser Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-sulfanylpropanamido]acetic acid

C12H21N5O7S (379.11616360000005)


   

Asn Ser Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]acetamido}-3-sulfanylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Ser Cys Gly Asn

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]acetamido}-3-carbamoylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Ser Cys Asn Gly

2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]acetic acid

C12H21N5O7S (379.11616360000005)


   

Ser Gly Cys Asn

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Ser Gly Asn Cys

(2R)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

Ser Asn Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]acetic acid

C12H21N5O7S (379.11616360000005)


   

Ser Asn Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]acetamido}-3-sulfanylpropanoic acid

C12H21N5O7S (379.11616360000005)


   

CAY10606

2-[(3-chlorophenyl)methyl]-5-hydroxy-1H-benz[g]indole-3-carboxylic acid, ethyl ester

C22H18ClNO3 (379.0975148)


   

Chondroitin

(2R,3R,4S)-2-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO11 (379.1114556)


   
   

N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide

N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide

C17H18BrNO4 (379.04191280000003)


   

2-[3-(2,6-dichlorophenyl)sulfanyl-2,5-dimethylindol-1-yl]acetic acid

2-[3-(2,6-dichlorophenyl)sulfanyl-2,5-dimethylindol-1-yl]acetic acid

C18H15Cl2NO2S (379.020051)


   
   

6-Oxo-2-phenyl-5-[[(phenylmethoxy)carbonyl]amino]-1(6H)-pyrimidineacetic acid

6-Oxo-2-phenyl-5-[[(phenylmethoxy)carbonyl]amino]-1(6H)-pyrimidineacetic acid

C20H17N3O5 (379.1168152)


   

1,2,3-Trimethyl-1-benzyl-1H-benzo[e]indolium bromide

1,2,3-Trimethyl-1-benzyl-1H-benzo[e]indolium bromide

C22H22BrN (379.09355120000004)


   
   

(S)-Fmoc-2-amino-4,4,4-trifluoro-butyric acid

(S)-Fmoc-2-amino-4,4,4-trifluoro-butyric acid

C19H16F3NO4 (379.10313720000005)


   

2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl [R-(R*,R*)]-aminoacetate

2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl [R-(R*,R*)]-aminoacetate

C13H15Cl2N3O6 (379.033787)


   

ETHYL 4-(3,5-DICHLOROPHENOXY)-1,3-DIMETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE

ETHYL 4-(3,5-DICHLOROPHENOXY)-1,3-DIMETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE

C17H15Cl2N3O3 (379.049042)


   
   

2-(3-BROMO-PHENYL)-6-(4-METHOXY-PHENYL)-PYRAZOLO[1,5-A]PYRIMIDINE

2-(3-BROMO-PHENYL)-6-(4-METHOXY-PHENYL)-PYRAZOLO[1,5-A]PYRIMIDINE

C19H14BrN3O (379.03201740000003)


   

benzyltrimethylammonium 1,1,3,3,3-pentafluoro-2-hydroxypropanesulfonate

benzyltrimethylammonium 1,1,3,3,3-pentafluoro-2-hydroxypropanesulfonate

C13H18F5NO4S (379.0876648000001)


   

2-[4-(2-phenyl-1,3-thiazol-4-yl)anilino]-1,3-thiazole-4-carboxylic acid

2-[4-(2-phenyl-1,3-thiazol-4-yl)anilino]-1,3-thiazole-4-carboxylic acid

C19H13N3O2S2 (379.0449158)


   

(1-methylpiperidin-4-yl) 2-chloro-2,2-diphenylacetate,hydrochloride

(1-methylpiperidin-4-yl) 2-chloro-2,2-diphenylacetate,hydrochloride

C20H23Cl2NO2 (379.1105758)


   

4-[(2E)-2-(8-oxoquinolin-5-ylidene)hydrazinyl]naphthalene-1-sulfonic acid

4-[(2E)-2-(8-oxoquinolin-5-ylidene)hydrazinyl]naphthalene-1-sulfonic acid

C19H13N3O4S (379.0626738000001)


   

FMOC-D,L-ALPHA-AMINO-2-THIOPHENACETIC ACID

FMOC-D,L-ALPHA-AMINO-2-THIOPHENACETIC ACID

C21H17NO4S (379.08782420000006)


   

TERT-BUTYL 4-(5-BROMO-1H-INDAZOL-3-YL)PIPERIDINE-1-CARBOXYLATE

TERT-BUTYL 4-(5-BROMO-1H-INDAZOL-3-YL)PIPERIDINE-1-CARBOXYLATE

C17H22BrN3O2 (379.0895292)


   

4,11-diamino-2-(3-methoxypropyl)-1H-Naphth[2,3-f]isoindole-1,3,5,10(2H)-tetrone

4,11-diamino-2-(3-methoxypropyl)-1H-Naphth[2,3-f]isoindole-1,3,5,10(2H)-tetrone

C20H17N3O5 (379.1168152)


   
   

N-methyl-2-nitro-4-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxyaniline

N-methyl-2-nitro-4-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxyaniline

C16H12F3N5O3 (379.0892198)


   

sodium,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetate

sodium,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetate

C19H15ClNNaO4 (379.0587260000001)


   

4-(3-(2,5-DIFLUOROPHENYL)-5,5-DIMETHYL-4-OXO-4,5-DIHYDROFURAN-2-YL)BENZENESULFONAMIDE

4-(3-(2,5-DIFLUOROPHENYL)-5,5-DIMETHYL-4-OXO-4,5-DIHYDROFURAN-2-YL)BENZENESULFONAMIDE

C18H15F2NO4S (379.0689814000001)


   

5-[(3-chlorophenyl)azo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-(phenylamino)nicotinonitrile

5-[(3-chlorophenyl)azo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-(phenylamino)nicotinonitrile

C19H14ClN5O2 (379.08359740000003)


   

(4-N-(Benzhydryloxycarbonyl)cytosine)-1-acetic acid

(4-N-(Benzhydryloxycarbonyl)cytosine)-1-acetic acid

C20H17N3O5 (379.1168152)


   

3-BROMO-1-(4-[5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]-1,4-DIAZEPAN-1-YL)PROPAN-1-ONE

3-BROMO-1-(4-[5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]-1,4-DIAZEPAN-1-YL)PROPAN-1-ONE

C14H17BrF3N3O (379.0507008)


   
   

L-689,560

(2R,4S)-4-[[anilino(oxo)methyl]amino]-5,7-dichloro-1,2,3,4-tetrahydroquinoline-2-carboxylic acid

C17H15Cl2N3O3 (379.049042)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists

   
   

N-cyclopentyl-5-(4-iodophenyl)-2-methylpyrimidin-4-amine

N-cyclopentyl-5-(4-iodophenyl)-2-methylpyrimidin-4-amine

C16H18IN3 (379.05454180000004)


   
   
   

dioxorhenium,ethane-1,2-diamine,hydrochloride

dioxorhenium,ethane-1,2-diamine,hydrochloride

C4H21ClN4O2Re (379.0910606)


   
   

6-BROMO-1-(TETRAHYDRO-2H-PYRAN-2-YL)-N-(TETRAHYDRO-2H-PYRAN-4-YL)-1H-INDAZOL-3-AMINE

6-BROMO-1-(TETRAHYDRO-2H-PYRAN-2-YL)-N-(TETRAHYDRO-2H-PYRAN-4-YL)-1H-INDAZOL-3-AMINE

C17H22BrN3O2 (379.0895292)


   

5-(3-((2S)-(1,4-Benzodioxan-2-ylmethyl)amino)propoxy)-1,3-benzodioxol hydrochloride

5-(3-((2S)-(1,4-Benzodioxan-2-ylmethyl)amino)propoxy)-1,3-benzodioxol hydrochloride

C19H22ClNO5 (379.11864320000007)


   

Fuzapladib

Fuzapladib

C15H20F3N3O3S (379.11774060000005)


C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C2144 - Endothelial-Specific Integrin/Survival Signaling Inhibitor D004791 - Enzyme Inhibitors > D064801 - Phospholipase A2 Inhibitors C308 - Immunotherapeutic Agent > C574 - Immunosuppressant Fuzapladib (IS-741), an orally active leukocyte-function-associated antigen type 1 (LFA-1) activation inhibitor, is a leukocyte adhesion molecule. Fuzapladib is also a phospholipase A2 (PLA2) inhibitor. Fuzapladib exerts anti-inflammatory effects by inhibiting leukocyte migration into the inflammatory site[1][2].

   

Dimethane sulfonate

Dimethane sulfonate

C14H21NO7S2 (379.0759396)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   

Methyl 2-(2-acetoxy-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-2-(2-chlorophenyl)acetate

Methyl 2-(2-acetoxy-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-2-(2-chlorophenyl)acetate

C18H18ClNO4S (379.0645018000001)


   
   

gamma-Glutamyl-cysteinyl-glutamic acid

gamma-Glutamyl-cysteinyl-glutamic acid

C13H21N3O8S (379.10493060000005)


   

2-chloro-N-(7-methyl-9-oxo-2-thioxanthenyl)benzamide

2-chloro-N-(7-methyl-9-oxo-2-thioxanthenyl)benzamide

C21H14ClNO2S (379.04337340000006)


   

2-(4-chlorophenyl)-N-[4-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]acetamide

2-(4-chlorophenyl)-N-[4-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]acetamide

C20H14ClN3O3 (379.0723644000001)


   

N-(4,7-dimethyl-1,3-benzothiazol-2-yl)-4-(2,5-dioxo-1-pyrrolidinyl)benzamide

N-(4,7-dimethyl-1,3-benzothiazol-2-yl)-4-(2,5-dioxo-1-pyrrolidinyl)benzamide

C20H17N3O3S (379.09905720000006)


   

4-amino-3-(4-ethoxyphenyl)-N-(2-oxolanylmethyl)-2-sulfanylidene-5-thiazolecarboxamide

4-amino-3-(4-ethoxyphenyl)-N-(2-oxolanylmethyl)-2-sulfanylidene-5-thiazolecarboxamide

C17H21N3O3S2 (379.1024276)


   

2-(4-benzofuro[3,2-d]pyrimidinylthio)-N-(2-ethoxyphenyl)acetamide

2-(4-benzofuro[3,2-d]pyrimidinylthio)-N-(2-ethoxyphenyl)acetamide

C20H17N3O3S (379.09905720000006)


   

2-[[1-(phenylmethyl)-3-indolyl]thio]-N-(2-thiazolyl)acetamide

2-[[1-(phenylmethyl)-3-indolyl]thio]-N-(2-thiazolyl)acetamide

C20H17N3OS2 (379.0812992)


   

3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

C18H14BrN5 (379.04325040000003)


   

3-Bromo-6-Phenyl-N-(Pyrimidin-5-Ylmethyl)imidazo[1,2-A]pyridin-8-Amine

3-Bromo-6-Phenyl-N-(Pyrimidin-5-Ylmethyl)imidazo[1,2-A]pyridin-8-Amine

C18H14BrN5 (379.04325040000003)


   

3-Bromo-5-Phenyl-N-(Pyrimidin-5-Ylmethyl)pyrazolo[1,5-A]pyridin-7-Amine

3-Bromo-5-Phenyl-N-(Pyrimidin-5-Ylmethyl)pyrazolo[1,5-A]pyridin-7-Amine

C18H14BrN5 (379.04325040000003)


   

3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

C18H14BrN5 (379.04325040000003)


   

7N-Methyl-8-hydroguanosine-5-monophosphate

7N-Methyl-8-hydroguanosine-5-monophosphate

C11H18N5O8P (379.0892958)


   

Pyridoxyl-glutamic acid-5-monophosphate

Pyridoxyl-glutamic acid-5-monophosphate

C13H20N2O9P+ (379.09063800000007)


   

beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GalpNAc

beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GalpNAc

C14H21NO11 (379.1114556)


An amino disaccharide consisting of N-acetyl-beta-D-galactosamine having a 4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl residue attached at the 3-position.

   

Meticillin sodium

Meticillin sodium

C17H19N2O6S- (379.09637740000005)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

(2E,6E)-3,7,11-Trimethyldodeca-2,6,10-trien-1-yl diphosphate

(2E,6E)-3,7,11-Trimethyldodeca-2,6,10-trien-1-yl diphosphate

C15H25O7P2-3 (379.107546)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

2-cis,6-trans-Farnesyl diphosphate(3-)

2-cis,6-trans-Farnesyl diphosphate(3-)

C15H25O7P2-3 (379.107546)


   

(2Z,6Z)-farnesyl diphosphate

(2Z,6Z)-farnesyl diphosphate

C15H25O7P2-3 (379.107546)


   

2-Amino-5-formylamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one

2-Amino-5-formylamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one

C10H14N5O9P-2 (379.0529124)


   

beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-D-GlcpNAc

beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-D-GlcpNAc

C14H21NO11 (379.1114556)


   
   

(2E,6Z)-farnesyl diphosphate

(2E,6Z)-farnesyl diphosphate

C15H25O7P2-3 (379.107546)


   

p-Nitrophenyl-beta-glucoside 6-phosphate

p-Nitrophenyl-beta-glucoside 6-phosphate

C12H14NO11P-2 (379.0304464)


   

[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(4-nitrophenoxy)oxan-2-yl]methyl phosphate

[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(4-nitrophenoxy)oxan-2-yl]methyl phosphate

C12H14NO11P-2 (379.0304464)


   

(2R,3R,4S)-2-[(2R,3R,4R,5R)-5-acetamido-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

(2R,3R,4S)-2-[(2R,3R,4R,5R)-5-acetamido-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO11 (379.1114556)


   

N-Hydroxyguanosine 5-phosphoric acid

N-Hydroxyguanosine 5-phosphoric acid

C10H14N5O9P (379.0529124)


   

4-Cyanobenzoic acid [6-[[(4-methyl-2-pyrimidinyl)thio]methyl]-4-oxo-3-pyranyl] ester

4-Cyanobenzoic acid [6-[[(4-methyl-2-pyrimidinyl)thio]methyl]-4-oxo-3-pyranyl] ester

C19H13N3O4S (379.0626738000001)


   

6-(4-fluoro-1,3-benzodioxol-5-yl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine

6-(4-fluoro-1,3-benzodioxol-5-yl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine

C20H14FN3O2S (379.0790716)


   

(2-Chloro-5-nitrophenyl)(4-(3-chlorophenyl)piperazin-1-yl)methanone

(2-Chloro-5-nitrophenyl)(4-(3-chlorophenyl)piperazin-1-yl)methanone

C17H15Cl2N3O3 (379.049042)


   

2-[[2-(4-Ethoxy-3-methoxyphenyl)-4-thiazolyl]methylthio]-5-methyl-1,3,4-thiadiazole

2-[[2-(4-Ethoxy-3-methoxyphenyl)-4-thiazolyl]methylthio]-5-methyl-1,3,4-thiadiazole

C16H17N3O2S3 (379.0482862)


   

5-(3,4-Dimethoxyphenyl)-2-(4-methylphenyl)-4-thieno[2,3-d][1,3]oxazinone

5-(3,4-Dimethoxyphenyl)-2-(4-methylphenyl)-4-thieno[2,3-d][1,3]oxazinone

C21H17NO4S (379.08782420000006)


   

Tetrakis(pyridine)copper(2+)

Tetrakis(pyridine)copper(2+)

C20H20CuN4+2 (379.098387)


   

N-[1-(2-methoxyphenyl)-5-benzimidazolyl]benzenesulfonamide

N-[1-(2-methoxyphenyl)-5-benzimidazolyl]benzenesulfonamide

C20H17N3O3S (379.09905720000006)


   

N-[4-(diethylamino)-2-methylphenyl]-2-[(2-nitro-3-thiophenyl)thio]acetamide

N-[4-(diethylamino)-2-methylphenyl]-2-[(2-nitro-3-thiophenyl)thio]acetamide

C17H21N3O3S2 (379.1024276)


   

Methyl 5-chloro-4-{[3-(4-chlorophenyl)acryloyl]amino}-2-methoxybenzoate

Methyl 5-chloro-4-{[3-(4-chlorophenyl)acryloyl]amino}-2-methoxybenzoate

C18H15Cl2NO4 (379.03780900000004)


   

N-[(4-sulfamoylanilino)-sulfanylidenemethyl]-1,3-benzodioxole-5-carboxamide

N-[(4-sulfamoylanilino)-sulfanylidenemethyl]-1,3-benzodioxole-5-carboxamide

C15H13N3O5S2 (379.0296608)


   

[[2-[5-(2-Chlorophenyl)-1-tetrazolyl]-6,8-dioxabicyclo[3.2.1]octan-4-ylidene]amino]thiourea

[[2-[5-(2-Chlorophenyl)-1-tetrazolyl]-6,8-dioxabicyclo[3.2.1]octan-4-ylidene]amino]thiourea

C14H14ClN7O2S (379.0618174)


   

N-(4-oxo-2-phenyl-1,2-dihydroquinazolin-3-yl)benzenesulfonamide

N-(4-oxo-2-phenyl-1,2-dihydroquinazolin-3-yl)benzenesulfonamide

C20H17N3O3S (379.09905720000006)


   

2-(4-chlorophenoxy)-N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)acetamide

2-(4-chlorophenoxy)-N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)acetamide

C20H14ClN3O3 (379.0723644000001)


   

2-(2-chlorophenyl)-9-(3-methylphenyl)-8-oxo-7H-purine-6-carboxamide

2-(2-chlorophenyl)-9-(3-methylphenyl)-8-oxo-7H-purine-6-carboxamide

C19H14ClN5O2 (379.08359740000003)


   

4-(2,5-dimethoxyphenyl)-3-(3-phenyl-1H-pyrazol-5-yl)-1H-1,2,4-triazole-5-thione

4-(2,5-dimethoxyphenyl)-3-(3-phenyl-1H-pyrazol-5-yl)-1H-1,2,4-triazole-5-thione

C19H17N5O2S (379.1102902)


   

2-(5-chloro-2-pyridinyl)-3-(4-ethoxyanilino)-3H-isoindol-1-one

2-(5-chloro-2-pyridinyl)-3-(4-ethoxyanilino)-3H-isoindol-1-one

C21H18ClN3O2 (379.1087478)


   

isopropyl 4-{[(4-bromo-1-ethyl-1H-pyrazol-5-yl)carbonyl]amino}benzoate

isopropyl 4-{[(4-bromo-1-ethyl-1H-pyrazol-5-yl)carbonyl]amino}benzoate

C16H18BrN3O3 (379.05314580000004)


   

N-[[3-chloro-2-(1-piperidinyl)anilino]-sulfanylidenemethyl]-2-thiophenecarboxamide

N-[[3-chloro-2-(1-piperidinyl)anilino]-sulfanylidenemethyl]-2-thiophenecarboxamide

C17H18ClN3OS2 (379.0579768)


   

(5E)-3-[(2-fluorophenyl)methyl]-5-[[1-(4-fluorophenyl)pyrrol-2-yl]methylidene]imidazolidine-2,4-dione

(5E)-3-[(2-fluorophenyl)methyl]-5-[[1-(4-fluorophenyl)pyrrol-2-yl]methylidene]imidazolidine-2,4-dione

C21H15F2N3O2 (379.1132274)


   

[4-[(E)-(pyridine-2-carbonylhydrazinylidene)methyl]phenyl] 2-chlorobenzoate

[4-[(E)-(pyridine-2-carbonylhydrazinylidene)methyl]phenyl] 2-chlorobenzoate

C20H14ClN3O3 (379.0723644000001)


   

2-[[5-(6-methyl-1H-benzimidazol-2-yl)-2-pyridinyl]thio]-N-(5-methyl-3-isoxazolyl)acetamide

2-[[5-(6-methyl-1H-benzimidazol-2-yl)-2-pyridinyl]thio]-N-(5-methyl-3-isoxazolyl)acetamide

C19H17N5O2S (379.1102902)


   

4-(1-methylsulfonyl-2,3-dihydroindol-5-yl)-N-(2-oxolanylmethyl)-2-thiazolamine

4-(1-methylsulfonyl-2,3-dihydroindol-5-yl)-N-(2-oxolanylmethyl)-2-thiazolamine

C17H21N3O3S2 (379.1024276)


   

1-[2-(4-Methylphenyl)-3-indolizinyl]-2-[(5-methyl-1,3,4-thiadiazol-2-yl)thio]ethanone

1-[2-(4-Methylphenyl)-3-indolizinyl]-2-[(5-methyl-1,3,4-thiadiazol-2-yl)thio]ethanone

C20H17N3OS2 (379.0812992)


   
   
   
   

tetracenomycin D3(1-)

tetracenomycin D3(1-)

C20H11O8- (379.0453906)


A hydroxy monocarboxylic acid anion that is the conjugate base of tetracenomycin F1, obtained by deprotonation of the carboxy group.

   

N-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]-1,3-benzodioxole-5-carboxamide

N-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]-1,3-benzodioxole-5-carboxamide

C19H13N3O6 (379.08043180000004)


   

methanesulfonic acid [(2R,5R)-2-(6-amino-2-chloro-9-purinyl)-4-hydroxy-5-(hydroxymethyl)-3-oxolanyl] ester

methanesulfonic acid [(2R,5R)-2-(6-amino-2-chloro-9-purinyl)-4-hydroxy-5-(hydroxymethyl)-3-oxolanyl] ester

C11H14ClN5O6S (379.0353294)


   

4-chloro-N-(3-hydroxy-2-methylindol-1-yl)-3-sulfamoylbenzamide

4-chloro-N-(3-hydroxy-2-methylindol-1-yl)-3-sulfamoylbenzamide

C16H14ClN3O4S (379.03935140000004)


   

2-[[3,4-Dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]amino]acetic acid

2-[[3,4-Dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]amino]acetic acid

C16H13NO10 (379.0539438)


   

[(3R,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-phosphonooxyoxan-2-yl] 2-aminobenzoate

[(3R,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-phosphonooxyoxan-2-yl] 2-aminobenzoate

C13H18NO10P (379.0668298)


   

4-chloro-N-(5-hydroxy-2-methylindol-1-yl)-3-sulfamoylbenzamide

4-chloro-N-(5-hydroxy-2-methylindol-1-yl)-3-sulfamoylbenzamide

C16H14ClN3O4S (379.03935140000004)


   

4-chloro-N-[(2S)-2-methyl-3-oxo-2H-indol-1-yl]-3-sulfamoylbenzamide

4-chloro-N-[(2S)-2-methyl-3-oxo-2H-indol-1-yl]-3-sulfamoylbenzamide

C16H14ClN3O4S (379.03935140000004)


   

2-(alpha-Furyl)-6-hydroxychromanone para-nitrobenzoate

2-(alpha-Furyl)-6-hydroxychromanone para-nitrobenzoate

C20H13NO7 (379.06919880000004)


   

(R)-S-Lactoylglutathione

(R)-S-Lactoylglutathione

C13H21N3O8S (379.10493060000005)


The S-[(R)-lactoyl] derivative of glutathione. It is an intermediate in the pyruvate metabolism. D000970 - Antineoplastic Agents

   

Gonyautoxin V

Gonyautoxin V

C10H17N7O7S (379.0910132)


D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms

   

3-(4-Deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-2-acetamido-2-deoxy-D-glucose

3-(4-Deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-2-acetamido-2-deoxy-D-glucose

C14H21NO11 (379.1114556)


   

N-acetyl-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-D-galactosamine

N-acetyl-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-D-galactosamine

C14H21NO11 (379.1114556)


   

2-({6-Amino-3,5-dicyano-4-[4-(cyclopropylmethoxy)phenyl]pyridin-2-yl}sulfanyl)acetamide

2-({6-Amino-3,5-dicyano-4-[4-(cyclopropylmethoxy)phenyl]pyridin-2-yl}sulfanyl)acetamide

C19H17N5O2S (379.1102902)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058913 - Purinergic Agonists BAY 60-6583 is a potent and high-affinity agonist of adenosine A2B receptor (EC50?= 3 nM) over A1, A2A, and A3 receptors. BAY 60-6583 binds to mouse, rabbit, and dog A2BAR with Ki values of 750 nM, 340 nM and 330 nM, respectively. BAY 60-6583 has a cardioprotective effect in a myocardial ischemia model[1][5].

   
   

beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GlcpNAc

beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GlcpNAc

C14H21NO11 (379.1114556)


An amino disaccharide consisting of N-acetyl-beta-D-glucosamine having a 4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl residue attached at the 3-position.

   

5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl hydrogen sulfate

5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl hydrogen sulfate

C16H17N3O4S2 (379.0660442)


An aryl sulfate obtained by sulfation of the phenolic hydroxy group of the anti-inflammatory drug, E3040. It is one of the major metabolites of E3040.

   

3-(4-deoxy-beta-D-gluc-4-enosyluronic acid)-N-acetyl-D-glucosamine

3-(4-deoxy-beta-D-gluc-4-enosyluronic acid)-N-acetyl-D-glucosamine

C14H21NO11 (379.1114556)


An amino disaccharide consisting of N-acetyl-beta-D-glucosamine having a 4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl residue attached at the 3-position.

   

2-trans,6-trans-farnesyl diphosphate(3-)

2-trans,6-trans-farnesyl diphosphate(3-)

C15H25O7P2 (379.107546)


An organophosphate oxoanion that is the trianion obtained by removal of the three protons from the diphosphate group of 2-trans,6-trans-farnesyl diphosphate.

   
   

Vicagrel

Vicagrel

C18H18ClNO4S (379.0645018000001)


Vicagrel is a potent, safe and orally active antiplatelet agent, which works by irreversibly inhibiting P2Y12 receptor. Vicagrel can be used for the research of blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease[1][2].

   

3-(1-hydroxyethyl)-6-(1h-indol-3-ylmethyl)-3,6-bis(methylsulfanyl)pyrazine-2,5-diol

3-(1-hydroxyethyl)-6-(1h-indol-3-ylmethyl)-3,6-bis(methylsulfanyl)pyrazine-2,5-diol

C17H21N3O3S2 (379.1024276)


   

n-sulfo{[(3as,4r,10as)-10,10-dihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxy}carboximidic acid

n-sulfo{[(3as,4r,10as)-10,10-dihydroxy-2,6-diimino-hexahydro-1h-pyrrolo[1,2-c]purin-4-yl]methoxy}carboximidic acid

C10H17N7O7S (379.0910132)


   

4-(3,4-dihydroxyphenyl)-2-(5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl)-2-(4-hydroxyphenyl)cyclopent-4-ene-1,3-dione

4-(3,4-dihydroxyphenyl)-2-(5-hydroxy-3,4-dihydro-2h-pyrrol-2-yl)-2-(4-hydroxyphenyl)cyclopent-4-ene-1,3-dione

C21H17NO6 (379.1055822)


   

(2s)-2-amino-4-{[(1r)-1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[(2r)-2-hydroxypropanoyl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid

(2s)-2-amino-4-{[(1r)-1-(carboxymethyl-c-hydroxycarbonimidoyl)-2-{[(2r)-2-hydroxypropanoyl]sulfanyl}ethyl]-c-hydroxycarbonimidoyl}butanoic acid

C13H21N3O8S (379.10493060000005)